Zazove Associates’s Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 CANO.WS Stock Holding History

Zazove Associates’s Portfolio CANO.WS Stock Details CANO.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-5,234,094	Closed	-$263K	–	140
2023 Q3	$263K	Hold	5,234,094	–	–	0.03%	107
2023 Q2	$1.18M	Hold	5,234,094	–	–	0.11%	89
2023 Q1	$774K	Sell	5,234,094 -4,381	-0.1%	-$1.29K	0.07%	103
2022 Q4	$1.17M	Buy	5,238,475 +4,554,018	+665%	+$3.95M	0.11%	99
2022 Q3	$1.79M	Buy	684,457 +555,007	+429%	+$817K	0.16%	82
2022 Q2	$91K	Hold	129,450	–	–	0.01%	152
2022 Q1	$207K	Buy	+129,450	New	+$187K	0.02%	146
2021 Q3	$536K	Hold	129,450	–	–	0.05%	125
2021 Q2	$487K	Buy	+129,450	New	+$585K	0.04%	127

Other funds holding CANO.WS

JAIC

Josh Arnold Investment Consultant Edina, Minnesota $117M AUM 26.5% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Zazove Associates's CANO.WS Position: Q4 2023 in Review

Zazove Associates sold out of Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 (CANO.WS) in Q4 2023, closing a stake of 5,234,094 shares — an estimated $263K sold.

Zazove Associates first reported a position in CANO.WS in Q2 2021 and held it in 9 quarters. The position peaked at $1.79M in Q3 2022. 2 funds tracked by Wall St. Rank hold CANO.WS as of Q4 2023.

Zazove Associates reported no remaining Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 position as of Q4 2023 after selling out during the quarter.
Zazove Associates sold 5,234,094 Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 shares in Q4 2023, an estimated $263K.
Zazove Associates first reported a position in Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 in Q2 2021 and held it in 9 quarters.
Zazove Associates's Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 position peaked at $1.79M in Q3 2022.
2 funds tracked by Wall St. Rank held Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 as of Q4 2023.

Based on Zazove Associates's 13F filing for Q4 2023, filed 31 Jan 2024.